Noevir Holdings Co., Ltd. (4928.T)
JPY 4120.0
(0.37%)
JPY 4120.0
(0.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 31.54 Billion JPY | -1.37% |
| 2022 | 31.97 Billion JPY | 30.68% |
| 2021 | 24.46 Billion JPY | -2.19% |
| 2020 | 25.01 Billion JPY | -4.57% |
| 2019 | 26.21 Billion JPY | 1.25% |
| 2018 | 25.89 Billion JPY | 0.47% |
| 2017 | 25.77 Billion JPY | 1.17% |
| 2016 | 25.47 Billion JPY | 1.92% |
| 2015 | 24.99 Billion JPY | 1.33% |
| 2014 | 24.66 Billion JPY | 4.71% |
| 2013 | 23.55 Billion JPY | 42.67% |
| 2012 | 16.51 Billion JPY | 0.0% |
| 2011 | - JPY | -100.0% |
| 2010 | 30.58 Billion JPY | -6.19% |
| 2009 | 32.6 Billion JPY | -3.9% |
| 2008 | 33.92 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.03 Billion JPY | 1.13% |
| 2024 Q2 | 7.49 Billion JPY | -6.67% |
| 2024 Q3 | 8.28 Billion JPY | 10.61% |
| 2023 Q3 | 8.08 Billion JPY | 8.08% |
| 2023 Q4 | 7.94 Billion JPY | -1.73% |
| 2023 Q1 | 8.04 Billion JPY | 0.21% |
| 2023 FY | 31.53 Billion JPY | -1.37% |
| 2023 Q2 | 7.47 Billion JPY | -7.03% |
| 2022 Q4 | 8.02 Billion JPY | -2.29% |
| 2022 FY | 31.97 Billion JPY | 30.68% |
| 2022 Q3 | 8.21 Billion JPY | 9.61% |
| 2022 Q2 | 7.49 Billion JPY | -9.15% |
| 2022 Q1 | 8.24 Billion JPY | 32.91% |
| 2021 FY | 24.46 Billion JPY | -2.19% |
| 2021 Q4 | 6.2 Billion JPY | -0.64% |
| 2021 Q1 | 6.17 Billion JPY | -0.4% |
| 2021 Q2 | 5.84 Billion JPY | -5.49% |
| 2021 Q3 | 6.24 Billion JPY | 6.93% |
| 2020 Q1 | 6.62 Billion JPY | -0.78% |
| 2020 Q2 | 6.07 Billion JPY | -8.39% |
| 2020 Q3 | 6.11 Billion JPY | 0.77% |
| 2020 Q4 | 6.2 Billion JPY | 1.42% |
| 2020 FY | 25.01 Billion JPY | -4.57% |
| 2019 Q4 | 6.67 Billion JPY | -0.52% |
| 2019 Q2 | 6.32 Billion JPY | -2.81% |
| 2019 FY | 26.21 Billion JPY | 1.25% |
| 2019 Q1 | 6.5 Billion JPY | -0.35% |
| 2019 Q3 | 6.71 Billion JPY | 6.2% |
| 2018 Q3 | 6.72 Billion JPY | 10.17% |
| 2018 FY | 25.89 Billion JPY | 0.47% |
| 2018 Q4 | 6.52 Billion JPY | -2.97% |
| 2018 Q2 | 6.1 Billion JPY | -6.52% |
| 2018 Q1 | 6.53 Billion JPY | -3.4% |
| 2017 Q3 | 6.3 Billion JPY | 4.08% |
| 2017 FY | 25.77 Billion JPY | 1.17% |
| 2017 Q1 | 6.64 Billion JPY | 1.61% |
| 2017 Q2 | 6.05 Billion JPY | -8.86% |
| 2017 Q4 | 6.76 Billion JPY | 7.25% |
| 2016 Q1 | 6.5 Billion JPY | 0.95% |
| 2016 FY | 25.47 Billion JPY | 1.92% |
| 2016 Q4 | 6.54 Billion JPY | 1.68% |
| 2016 Q3 | 6.43 Billion JPY | 7.29% |
| 2016 Q2 | 5.99 Billion JPY | -7.75% |
| 2015 Q2 | 5.8 Billion JPY | -6.13% |
| 2015 FY | 24.99 Billion JPY | 1.33% |
| 2015 Q4 | 6.44 Billion JPY | -1.93% |
| 2015 Q1 | 6.18 Billion JPY | 2.7% |
| 2015 Q3 | 6.56 Billion JPY | 13.15% |
| 2014 Q4 | 6.02 Billion JPY | -7.35% |
| 2014 Q1 | 6.25 Billion JPY | 2.07% |
| 2014 Q3 | 6.49 Billion JPY | 10.18% |
| 2014 FY | 24.66 Billion JPY | 4.71% |
| 2014 Q2 | 5.89 Billion JPY | -5.65% |
| 2013 Q2 | 5.47 Billion JPY | -11.0% |
| 2013 Q4 | 6.12 Billion JPY | 5.38% |
| 2013 Q3 | 5.81 Billion JPY | 6.17% |
| 2013 Q1 | 6.14 Billion JPY | 329.46% |
| 2013 FY | 23.55 Billion JPY | 42.67% |
| 2012 Q3 | 6.46 Billion JPY | 7.11% |
| 2012 FY | 16.51 Billion JPY | 0.0% |
| 2012 Q1 | 6.69 Billion JPY | 258.58% |
| 2012 Q2 | 6.03 Billion JPY | -9.95% |
| 2012 Q4 | -2.68 Billion JPY | -141.48% |
| 2011 Q3 | 6.9 Billion JPY | 0.0% |
| 2011 FY | - JPY | -100.0% |
| 2011 Q4 | 1.86 Billion JPY | -72.93% |
| 2010 FY | 30.58 Billion JPY | -6.19% |
| 2009 FY | 32.6 Billion JPY | -3.9% |
| 2008 FY | 33.92 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Kitanotatsujin Corporation | 9.38 Billion JPY | -236.136% |
| Euglena Co., Ltd. | 34.45 Billion JPY | 8.452% |
| BEAUTY GARAGE Inc. | 5.8 Billion JPY | -443.769% |
| Axas Holdings Co.,Ltd. | 3 Billion JPY | -951.18% |
| C.I. Medical Co.,Ltd. | 9 Billion JPY | -250.211% |
| Kao Corporation | 438.95 Billion JPY | 92.815% |
| Niitaka Co., Ltd. | 6.65 Billion JPY | -373.591% |
| Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 73.097% |
| Shiseido Company, Limited | 696.62 Billion JPY | 95.472% |
| Lion Corporation | 160.09 Billion JPY | 80.299% |
| Mandom Corporation | 29.51 Billion JPY | -6.879% |
| Ivy Cosmetics Corporation | 1.72 Billion JPY | -1728.011% |
| Milbon Co., Ltd. | 24 Billion JPY | -31.416% |
| Nippon Shikizai, Inc. | 2.31 Billion JPY | -1264.33% |
| Fancl Corporation | 61.61 Billion JPY | 48.814% |
| KOSÉ Corporation | 189.85 Billion JPY | 83.388% |
| Cota Co., Ltd. | 4.25 Billion JPY | -641.57% |
| HABA Laboratories,Inc. | 8.21 Billion JPY | -283.986% |
| C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | -395.09% |
| Pola Orbis Holdings Inc. | 119.68 Billion JPY | 73.647% |
| Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -1002.163% |
| Almado, Inc. | 4.11 Billion JPY | -667.301% |
| I-ne CO., LTD. | 17.86 Billion JPY | -76.546% |
| Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | -97.607% |
| Liberta Co.,Ltd. | 2.68 Billion JPY | -1076.372% |
| AXXZIA Inc. | 8.57 Billion JPY | -267.924% |
| S.T. Corporation | 15.07 Billion JPY | -109.248% |
| Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 55.323% |
| Earth Corporation | 57.25 Billion JPY | 44.913% |
| Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -1907.959% |
| Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -2329.029% |
| Ya-Man Ltd. | 18.49 Billion JPY | -70.503% |
| MTG Co., Ltd. | 33.26 Billion JPY | 5.177% |
| TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -589.179% |
| SHOBIDO Corporation | 4.5 Billion JPY | -600.829% |
| Artnature Inc. | 25.01 Billion JPY | -26.084% |
| Pigeon Corporation | 34.72 Billion JPY | 9.177% |
| Unicharm Corporation | 351.52 Billion JPY | 91.028% |
| Paltac Corporation | 53.06 Billion JPY | 40.56% |
| CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | -128.799% |